| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Yk Bioventures Opportunities GP I, LLC last filed a Form 4 in December 2024, as 10% Owner at CERO.
At the last filing, the largest reported position was 13,005,169 shares of CERO. The CERO filings lean toward selling, a net 12,865,614 shares.
Yk Bioventures Opportunities GP I, LLC has 3 Form 4 filings on record from October 2024 to December 2024, all as 10% Owner at Cero Therapeutics (CERO), 2024.
The 7 reported transactions were 7 open-market sales.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $1.1M.
The largest open-market sale was 5,957,250 shares of CERO at an average $0.07 on December 13, 2024, about $400K.
None of the 3 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
Shares as reported in the last Form 4 for each company; the most recent is from December 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | CERO Cero Therapeutics Holdings, Inc. | 10% Owner | Sell | 5,957,250 | $0.07 | $400,456.43 | -31.4% | |
| Dec 10, 2024 | CERO Cero Therapeutics Holdings, Inc. | 10% Owner | Sell | 3,658,364 | $0.10 | $383,369.84 | -16.2% | |
| Oct 10, 2024 | CERO Cero Therapeutics Holdings, Inc. | 10% Owner | Sell | 3,250,000 | $0.10 | $325,000.00 | -12.6% |